» Articles » PMID: 27887931

Revision of Primary Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Indications and Outcomes from a High-volume Center

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2016 Nov 27
PMID 27887931
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Laparoscopic sleeve gastrectomy (SG) has become an accepted primary bariatric operation. Like other bariatric operations, inadequate weight loss and complications have been reported.

Objectives: The aim of this study was to assess the indications and outcomes of revision of SG to laparoscopic Roux-en-Y gastric bypass (RYGB) at a single community hospital.

Setting: Community hospital, United States.

Methods: Retrospective review of a prospectively collected database identifying SG operations done from February 2009 to June 2014. All patients who underwent revision from SG to RYGB were studied.

Results: Forty-eight patients underwent revision of SG to RYGB. Mean time to revision was 26 months (range, 2-60 mo) and mean follow up after RYGB was 20 months (range, 4-48 mo). Indications for revision were reflux (n = 14), inadequate weight loss (n = 11), reflux and inadequate weight loss (n = 16), stricture (n = 4), chronic leak (n = 1), and recurrent diabetes and reflux (n = 2). Reflux symptoms resolved in 96% of patients after revision, and hiatal hernias were repaired in 50% of patients. Percentage total weight loss at 3, 6, 12, 24, and 36 months was 9.0%, 12.9%, 15.7%, 13.3%, and 6.5%, respectively. The overall rate of complication was 31%. There were no mortalities.

Conclusions: Revision of SG to RYGB is a potentially effective means of treating SG complications, particularly reflux. Reflux was the most common indication for revision and was often associated with a hiatal hernia. Further studies will be necessary to evaluate the long-term maintenance of additional weight loss after revision of SG to RYGB.

Citing Articles

Long-Term Outcomes of Laparoscopic Roux-en-Y Gastric Bypass vs Laparoscopic Sleeve Gastrectomy for Obesity: The SM-BOSS Randomized Clinical Trial.

Kraljevic M, Susstrunk J, Wolnerhanssen B, Peters T, Bueter M, Gero D JAMA Surg. 2025; .

PMID: 39969869 PMC: 11840683. DOI: 10.1001/jamasurg.2024.7052.


Bariatric surgery and relevant comorbidities: a systematic review and meta-analysis.

Wunker C, Kumar S, Hallowell P, Collings A, Loss L, Bansal V Surg Endosc. 2025; 39(3):1419-1448.

PMID: 39920373 PMC: 11870965. DOI: 10.1007/s00464-025-11528-4.


Prognosticating post-bariatric surgery outcomes and management of postoperative recurrent weight gain and diabetes recurrence.

Xiao H, Du Y, Tan Y, Ren Y Front Nutr. 2025; 11:1510403.

PMID: 39764413 PMC: 11700827. DOI: 10.3389/fnut.2024.1510403.


Outcomes following reoperative bariatric surgery following laparoscopic sleeve gastrectomy at a tertiary care centre.

Singla V, Monga S, Kumar A, Ghosh T, Yadav B, Gupta M J Minim Access Surg. 2024; 20(3):247-252.

PMID: 39047676 PMC: 11354943. DOI: 10.4103/jmas.jmas_125_23.


Challenges of Revisional Metabolic and Bariatric Surgery: A Comprehensive Guide to Unraveling the Complexities and Solutions of Revisional Bariatric Procedures.

Evans L, Castillo-Larios R, Cornejo J, Elli E J Clin Med. 2024; 13(11).

PMID: 38892813 PMC: 11172990. DOI: 10.3390/jcm13113104.